首页 | 本学科首页   官方微博 | 高级检索  
检索        

恶性肿瘤患者化疗前后免疫功能状况及胸腺五肽等的调节作用
引用本文:李焱,王士勇,于环,宋利,杜微丽,陈维信.恶性肿瘤患者化疗前后免疫功能状况及胸腺五肽等的调节作用[J].中华肿瘤防治杂志,2007,14(12):924-927.
作者姓名:李焱  王士勇  于环  宋利  杜微丽  陈维信
作者单位:中国医科大学附属第四医院肿瘤生物治疗科和中心实验室,辽宁,沈阳,110032
基金项目:教育部归国博士启动课题
摘    要:目的:研究恶性肿瘤患者的免疫功能状态和调节免疫功能的治疗方法。方法:分别用免疫细胞化学法和生化法检测95例恶性肿瘤患者和18名健康人的细胞免疫功能(CD3、CD4、CD8和CD56)和体液免疫功能(C3、C4、IgA、IgM和IgG);比较不同治疗方法对患者免疫指标的影响。结果:38例初诊和47例化疗后恶性肿瘤患者与18名健康人的细胞免疫功能比较,肿瘤患者的CD3、CD4和CD4/CD8明显低于健康人,CD8(除生物治疗后)和CD56明显高于健康人,但初诊和化疗后患者间差异无统计学意义,P〈0.05。经胸腺五肽(欧宁)治疗后的22例患者,CD3比例略有上升,CD4和CD4/CD8明显上升,CD8明显下降,CD56略有下降。经中药治疗的16例患者,CD4略有上升,CD8比例明显降低,CD4/CD8明显增高。肿瘤患者与健康人比较,IgG明显高于健康人;经胸腺五肽和中药治疗后,体液免疫功能无明显变化。结论:恶性肿瘤患者细胞免疫功能低下,体液免疫功能基本正常;胸腺五肽和中药治疗后均明显改善了患者的细胞免疫功能,但仍达不到健康人水平;两种治疗方法对体液免疫功能影响不大。

关 键 词:肿瘤/药物疗法  胸腺素/治疗应用  肿瘤/免疫学
文章编号:1673-5269(2007)12-0924-04
收稿时间:2006-08-15
修稿时间:2006-08-152006-12-01

Comparison of immune function between before and after chemotherapy of patients with malignant tumors and immune regulatory function of drugs
LI Yan,WANG Shi-yong,YU Huan,SONG Li,DU Wei-li,CHEN Wei-xin.Comparison of immune function between before and after chemotherapy of patients with malignant tumors and immune regulatory function of drugs[J].Chinese Journal of Cancer Prevention and Treatment,2007,14(12):924-927.
Authors:LI Yan  WANG Shi-yong  YU Huan  SONG Li  DU Wei-li  CHEN Wei-xin
Institution:Department of Cancer Biotherapy and Laboratory Center, Fourth Affiliated Hospital of China Medical University, Shenyang 110032, P. R. China
Abstract:OBJECTIVE: To investigate the immune function of patients with malignant tumors and study the therapy methods to regulate the immune function. METHODS: The cellular immune (CD3, CD4, CD8, CD56) was tested in 95 malignant patients and 18 normal persons by the immunocytochemistry method and the humoral immunity (C3, C4, IgA, IgM, IgG) by the biochemistry method. The treatment effects on immune was compared between before and after chemotherapy, thymopentin and Chinese herbs. RESULTS: CD3, CD4 and the ratio of CD4/CD8 of 38 malignant patients with preliminary diagnosis and 47 cases after chemotherapy were significanfly lower than those of 18 normal persons as control, and CD8 (except after biotherapy group) and CD56 were much higher than the normal, but there was no significant difference between the two malignant groups. Twenty-two cases among the malignant patients, CD3 increased a little, with CD4 and the ratio of CD4/CD8 increasing obviously after the treatment of thymopentin. However, CD8 decreased evidently and CD56 decreased a little. Of 16 cases after treatment with Chinese herbs, CD4 increased without statistic significance, CD8 decreased obviously,but CD4/CD8 increased obviously. Compared the malignant with the normal, IgG was much higher. No visible change in humoral immune was found in the malignant patients treated with thymopentin and Chinese herbs. CONCLUSIONS: Malignant patients have lower cellular immune and normal humoral immune. The cellular immune of patients is still lower than that of the normal though thymopentin and Chinese herbs can improve it; neither can improve humoral immune.
Keywords:neoplasms/drug therapy  thymosin/therapeutic uses  neoplasms/immunologic
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号